Guillaume Corpart
When considering the leading healthcare markets around the world, North America and Europe are usually the first two regions that come to mind. However, Latin America is steadily ascending as a center of clinical excellence and medical innovation.
According to a recent analysis of Brand Finance’s Global Top 250 Hospitals report, hospital brand strength is a critical driver of patient choice, institutional prestige, and clinician recruitment. The data reveals that Brazil has officially entered the top 10 countries worldwide for top-rated hospital brands. Boasting three hospital brands in the global top 100, Brazil now stands on par with advanced healthcare hubs.
For MedTech executives, this transformation signals a fast-growing market eager for advanced medical devices, robotics, and digital health solutions. As Latin American facilities build a worldwide reputation, commercial teams must align their market access strategies to meet this demand.
Decoding the Statista & Newsweek Rankings: The Elite Private Sector
The global recognition of Latin American healthcare is strongly echoed by detailed regional evaluations. In the 2026 ranking of Latin America’s Top Private Hospitals & Clinics — a comprehensive list developed by Newsweek in partnership with Statista — the region’s elite institutions demonstrate world-class capabilities. Leading the list is Brazil’s Hospital Israelita Albert Einstein in São Paulo, which secured the number-one rank across multiple high-acuity specialties, including refractive eye surgeries, and the number-two rank in orthopedic knee and hip replacements.
The excellence extends beyond Brazil. The ranking highlights a highly competitive network of top-tier private hospitals, including Colombia’s Fundación Santa Fe de Bogotá, Chile’s Clínica Alemana Vitacura, and Argentina’s Hospital Italiano de Buenos Aires. These institutions dominate the region in high-margin, complex procedures. For example, Fundación Santa Fe de Bogotá ranks first in the region for knee and shoulder surgeries, while Hospital Italiano de Buenos Aires ranks within the top five for both hip and knee procedures.
For MedTech sales teams, these elite facilities represent prime targets. Hospitals engaging in high-volume, highly specialized procedures are actively seeking premium, cutting-edge medical devices. They prioritize clinical excellence and rapid patient recovery, making them ideal early adopters for high-end robotic surgery platforms, advanced diagnostic imaging, and innovative surgical tools. By targeting these elite private centers, MedTech firms can establish strong footholds and key opinion leader (KOL) networks that influence procurement trends across the broader regional market.
Mexico: The Supply Chain and Manufacturing Titan
While South America captures significant attention for hospital brand prestige, Mexico is the backbone of the region’s MedTech supply chain. Over the last few years, Mexico has transitioned from a secondary manufacturing option to the primary production platform for most major device Original Equipment Manufacturers (OEMs). Currently, Mexico is the single largest source of imported medical devices sold in the United States, accounting for roughly one in five devices imported annually.
In 2024, Mexico generated $19.3 billion in medical device exports, solidifying its rank as the sixth-largest medical device exporter globally. Several structural forces are driving this dominance. The economics of domestic U.S. medical device production are tightening due to compressed profit margins, rising input costs, and increased regulatory burdens. Considering that medical device manufacturing is highly labor-intensive and labor costs in Mexico are 40% to 60% below U.S. levels, the nation has a massive strategic and economic advantage.
Furthermore, trade and tariff policies are fundamentally reshaping global supply chains. High tariffs on Asian imports have made overseas components significantly more expensive, while Mexico, operating under the USMCA framework, offers a highly favorable and tariff-efficient production environment.
Mexico currently has over 250 companies manufacturing medical devices, with massive clusters located in border states like Baja California and in Nuevo Leon, which serves as a leading hub for electronic medical equipment manufacturing. For global MedTech companies, expanding production or partnering with manufacturers in Mexico is critical to protecting profit margins while ensuring supply chain resilience.
The Surge in Medical Device Contract Manufacturing
Along with a growing medical device export market in countries like Mexico, Latin America is also experiencing greater internal demand for healthcare technology created within the region. These two factors are driving a major boom in Latin America’s medical device contract manufacturing sector.
Latin American Medical Device Contract Manufacturing by the Numbers
- Market value in 2024: $3.4b
- Projected market value by 2032: $7.4b
- Projected compound annual growth rate (CAGR): 2%
This growth is fueled by an expanding middle class, an aging population, and rising healthcare expenditures that require advanced diagnostic tools, surgical instruments, and patient monitoring systems. Additionally, Latin America is becoming a preferred outsourcing destination for North American and European companies seeking competitive cost structures and favorable exchange rates without sacrificing proximity to key markets.
A prominent trend in this sector is the expansion of outsourcing partnerships between regional manufacturers and international device companies. Regional manufacturers are increasingly adopting advanced production technologies, such as automation and 3D printing, and placing greater emphasis on regulatory compliance to align with strict international standards.
Brazil currently holds the largest market share in this regional sector at approximately 45%, with Mexico and Argentina also serving as key players. MedTech leaders can capitalize on this trend by establishing regional manufacturing partnerships, thereby reducing time-to-market and lowering production costs for devices intended for both local consumption and international export.
Strategic Imperatives for MedTech Growth
As Latin American healthcare rapidly evolves, MedTech commercial teams must adapt their strategies to stay ahead. The data makes one thing clear: the region is no longer a secondary, emerging market — it is a sophisticated landscape demanding world-class solutions. To capitalize on these shifts, MedTech executives must focus on targeted market access, supply chain optimization, and deep regional intelligence.
By understanding the intersection of hospital brand prestige, procedure volumes at top private clinics, and the nearshoring manufacturing boom in Mexico, MedTech companies can position themselves as indispensable partners. Winning in Latin America requires a strategy that leverages local manufacturing efficiencies to deliver cutting-edge technologies. As the prestige of hospitals in the region continues to rise, their purchasing power and demand for innovation will grow with it.
Next Steps
Contact GHI to learn more about the evolving landscape of clinical excellence and manufacturing shifts across Latin America and how you can adjust your market access strategy to engage with the region’s healthcare providers. Our team of researchers can provide the deep regional intelligence and supply chain analysis you need to gain valuable insights to support strategic decision-making in your industry.
************
Sources:
https://www.visualcapitalist.com/dp/mapped-countries-with-the-most-top-rated-hospitals/
https://rankings.newsweek.com/latin-americas-top-private-hospitals-clinics-2026
https://insights.tetakawi.com/overview-of-medical-device-manufacturing-in-mexico
https://www.ivemsa.com/medical-device-manufacturing-mexico-overview/
https://www.credenceresearch.com/report/latin-america-medical-device-contract-manufacturing-market
